↓ Skip to main content

Wiley Online Library

The next step in translational research: lessons learned from the first preclinical randomized controlled trial

Overview of attention for article published in Journal of Neurochemistry, March 2016
Altmetric Badge

Citations

dimensions_citation
46 Dimensions

Readers on

mendeley
50 Mendeley
Title
The next step in translational research: lessons learned from the first preclinical randomized controlled trial
Published in
Journal of Neurochemistry, March 2016
DOI 10.1111/jnc.13516
Pubmed ID
Authors

Gemma Llovera, Arthur Liesz

Abstract

For years, low reproducibility of preclinical trials and poor translation of promising preclinical therapies to the clinic have posed major challenges to translational research in most biomedical fields. To overcome the limitations that stand between experimental and clinical research, international consortia have attempted to establish standardized guidelines for study design and for reporting the resulting data. In addition, multicenter preclinical randomized controlled trials (pRCTs) have been proposed as a suitable tool for 'bridging the gap' between experimental research and clinical trials. We recently reported the design and results of the first such pRCT in which we confirmed the feasibility of using a coordinated approach with standardized protocols in collaboration with independent multinational research centers. However, despite its successes, this first pRCT also had several difficulties, particularly with respect to following the protocols established in the study design and analyzing the data. Here, we review our experiences performing the study, and we analyze and discuss the lessons learned from performing the first pRCT. Moreover, we provide suggestions regarding how obstacles can be overcome to improve the performance and outcome of future pRCT studies. Translational research is hampered by low reproducibility of preclinical studies and countless failed clinical trials. International consortia have proposed preclinical multicenter trials as an intermediate step to overcome this 'translational roadblock'. We have recently performed the first such preclinical randomized controlled trial (pRCT) by adopting key elements of clinical study design to preclinical research. In this review, we discuss the lessons learned from this trial and provide suggestions how to optimize future pRCTs. This article is part of the 60th Anniversary special issue.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
Unknown 49 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 14%
Researcher 7 14%
Student > Master 6 12%
Other 4 8%
Student > Doctoral Student 4 8%
Other 13 26%
Unknown 9 18%
Readers by discipline Count As %
Medicine and Dentistry 6 12%
Agricultural and Biological Sciences 6 12%
Neuroscience 6 12%
Pharmacology, Toxicology and Pharmaceutical Science 3 6%
Immunology and Microbiology 2 4%
Other 13 26%
Unknown 14 28%